2022
- Israel E, Cardet JC, Carroll JK, Fuhlbrigge AL, She L, Rockhold FW, Maher NE, Fagan M, Forth VE, Yawn BP, Arias Hernandez P, Kruse JM, Manning BK, Rodriguez-Louis J, Shields JB, Ericson B, Colon-Moya AD, Madison S, Coyne-Beasley T, Hammer GM, Kaplan BM, Rand CS, Robles J, Thompson O, Wechsler ME, Wisnivesky JP, McKee MD, Jariwala SP, Jerschow E, Busse PJ, Kaelber DC, Nazario S, Hernandez ML, Apter AJ, Chang KL, Pinto-Plata V, Stranges PM, Hurley LP, Trevor J, Casale TB, Chupp G, Riley IL, Shenoy K, Pasarica M, Calderon-Candelario RA, Tapp H, Baydur A, Pace WD. Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma. N Engl J Med. 2022 Apr 21;386(16):1505-1518.
- Nazario S, González-Sepúlveda L, Telón-Sosa B, Suárez-Pérez EL. Inequalities in asthma mortality by ethnicity and race in the United States and Puerto Rico. J Allergy Clin Immunol Pract. 2022 Aug;10(8):2178-2180.
- Diaz-Ramos N, Nazario S, Malinow-Maceo I. Fixed drug eruption to aripiprazole, cetirizine, and hydroxyzine hydrochloride. Ann Allergy Asthma Immunol. 2022 Dec 12:S1081-1206(22)01992-5.